a generic version of ADVAIR ?
The country's second largest drug firm Cipla
has been in favour of alliances to grow its footprint. It has joined hands with
the world's largest generic company Teva to sell its products in certain
markets. This
alliance could turn out to be the most critical for Cipla, reports
CNBC-TV18's Archana Shukla.
The partnership, which begins for the Russian market, sees Teva provide the
marketing muscle to sell Cipla's key inhaler brand Seroflo. Seroflo is the
generic version of GSK's USD 8 billion combination inhaler brand Advair.
see article on this Russian generic from generic major Teva
No comments:
Post a Comment